Results 121 to 130 of about 23,209 (275)

Clinically meaningful treatment responses after switching to galantamine and with addition of memantine in patients with Alzheimer’s disease receiving donepezil

open access: yesNeuropsychiatric Disease and Treatment, 2013
Osamu Kano,1 Hirono Ito,1 Takanori Takazawa,1 Yuji Kawase,1 Kiyoko Murata,1 Konosuke Iwamoto,1 Tetsuro Nagaoka,1 Takehisa Hirayama,1 Ken Miura,1 Riya Nagata,1 Tetsuhito Kiyozuka,2 Jo Aoyagi,2 Ryuta Sato,2 Teruo Eguchi,3 Ken Ikeda,1 Yasuo ...
Kano O   +15 more
doaj  

Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine

open access: yesSchizophrenia Research: Cognition, 2016
The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) project designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia, identified three drug mechanisms ...
Maju Mathew Koola
doaj   +1 more source

Cross-cultural adaptation of the disability assessment for dementia (DAD) [PDF]

open access: yes, 2007
The original version of the Disability Assessment for Dementia (DAD) was translated into Portuguese and back translated to English. The divergences of translation were identified and discussed, resulting in a version that was used in a preliminary ...
Areza-fegyveres, Renata   +6 more
core   +2 more sources

Acetylcholinesterase Inhibitor Ameliorates Early Cardiometabolic Disorders in Fructose-Overloaded Rat Offspring

open access: yesPharmaceuticals
Background: We investigate the role of galantamine on autonomic dysfunction associated with early cardiometabolic dysfunction in the offspring of fructose-overloaded rats.
Victor Hugo Martins de Miranda   +7 more
doaj   +1 more source

Validity, Significance, Strengths, Limitations, and Evidentiary Value of Real-World Clinical Data for Combination Therapy in Alzheimer's Disease: Comparison of Efficacy and Effectiveness Studies [PDF]

open access: yes, 2014
Background: Randomized controlled efficacy trials (RCTs), the scientific gold standard, are required for regulatory approval of Alzheimer's disease (AD) interventions, yet provide limited information regarding real-world therapeutic effectiveness ...
Atri, Alireza   +3 more
core   +1 more source

Galantamine as a Potential Treatment for Peripheral Nerve Injuries: Emphasis on Non-Systemic Delivery

open access: yesFuture Pharmacology
Peripheral nerve injuries can lead to significant functional impairments, and treatment options remain limited. Galantamine, widely used for cognitive disorders, has shown potential effects on the peripheral nervous system, making it a candidate for new ...
Mariya Ivanova   +5 more
doaj   +1 more source

Characteristic Effects of Anti-dementia Drugs on Rat Sleep Patterns

open access: yesJournal of Pharmacological Sciences, 2009
The present study was undertaken to clarify the effects of anti-dementia drugs on sleep pattern in rats. Electrodes were chronically implanted into the frontal cortex and the dorsal neck muscle of rats for the electroencephalogram (EEG) and ...
Takayuki Ishida, Chiaki Kamei
doaj   +1 more source

HPMC-based fast-dissolving oral films with galantamine-loaded chitosan nanoparticles [PDF]

open access: yesPharmacia
Alzheimer’s disease is a brain disorder characterized by a gradual decline in memory, thinking, behavior, and social skills. Galantamine hydrobromide is a reversible competitive cholinesterase inhibitor used for managing Alzheimer’s disease.
Dilyana Georgieva, Bistra Kostova
doaj   +3 more sources

Home - About - Disclaimer - Privacy